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The data of a corresponding animal experiment demonstrates that
nebulized methacholine (MCh) induced severe bronchoconstric-
tion and signiﬁcant inhomogeneous ventilation and pulmonary
perfusion (V̇A/Q̇) distribution in pigs, which is similar to ﬁndings in
human asthma. The inhalation of MCh induced bronchoconstric-
tion and delayed both uptake and elimination of desﬂurane
(Kretzschmar et al., 2015) [1].
The objective of the present data is to determine V̇A/Q̇
matching by Multiple Inert Gas Elimination Technique (MIGET) in
piglets before and during methacholine- (MCh-) induced bronch-
oconstriction, induced by MCh infusion, and to assess the blood
concentration proﬁles for desﬂurane (DES) by Micropore Mem-
brane Inlet Mass Spectrometry (MMIMS).
Healthy piglets (n¼4) under general anesthesia were instru-
mented with arterial, central venous, and pulmonary artery lines.vier Inc. This is an open access article under the CC BY license
/j.resp.2015.09.014
arch Council (5315 and X2015-99x-22731-01-04), Stockholm, Sweden, the
, and by institutional sources of the Uppsala University, Uppsala, Sweden,
Magdeburg, Germany.
esthesiology and Intensive Care Medicine, Otto-von-Guericke-University,
el.: þ49 391 6713500; fax: þ49 391 6713501.
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essing the experiments, in analyzing the data, and in preparing of the
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A. Kozian et al. / Data in Brief 5 (2015) 939–947940The airway was secured via median tracheostomy with an endo-
tracheal tube, and animals were mechanically ventilated with
intermittent positive pressure ventilation (IPPV) with a FiO2 of 0.4,
tidal volume (VT)¼10 ml/kg and PEEP of 5cmH2O using an open
system. The determination of V
.
A/Q
.
was done by MIGET: before
desﬂurane application and at plateau in both healthy state and
during MCh infusion. Arterial blood was sampled at 0, 1, 2, 5, 10,
20, and 30 min during wash-in and washout, respectively.
Bronchoconstriction was established by MCH infusion aiming
at doubling the peak airway pressure, after which wash-in and
washout of the anesthetic gas was repeated. Anesthesia gas con-
centrations were measured by MMIMS. Data were analyzed by
ANOVA, paired t-test, and by nonparametric Friedman's test and
Wilcoxon's matched pairs test.
We measured airway pressures, pulmonary resistance, and
mean paO2 as well as hemodynamic variables in all pigs before
desﬂurane application and at plateau in both healthy state and
during methacholine administration by infusion. By MIGET, frac-
tional alveolar ventilation and pulmonary perfusion in relation to
the V
.
A/Q
.
compartments, data of logSDQ̇ and logSDV̇ (the second
moments describing global dispersion, i.e. heterogeneity of dis-
tribution) were estimated prior to and after MCh infusion. The
uptake and elimination of desﬂurane was determined by MMIMS.
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations TableSubject area Biochemistryore speciﬁc sub-
ject areaRespiratory Physiology, Pharmacokineticsype of data Tables, text ﬁle, graph, ﬁgure
ow data was
acquiredMass Spectrometry, Multiple Inert Gas Elimination Techniqueata format Calculated and statistically analyzed data in tables and ﬁgures
xperimental
factorsRespiratory physiology determined before desﬂurane application and at
plateau in both healthy state and during methacholine infusionxperimental
featuresMultiple Inert Gas Elimination Technique allows the determination of ven-
tilation and pulmonary perfusion distribution. The uptake and elimination of
desﬂurane in arterial blood was determined by Micropore Membrane Inlet
Mass Spectrometryata source
locationUniversity of Uppsala, Uppsala, Swedenata accessibility Data is provided within this articleD
Value of the data
 The potential changes of uptake and elimination of a volatile anesthetic on the basis of uneven
distribution of ventilation and/or pulmonary perfusion have not been demonstrated yet.
 This experimental data provides insights on how the pharmacokinetics of volatile anesthetics is
affected by bronchoconstriction and calculated ventilation/perfusion (V̇A/Q̇) ratios depending on
intravenous administration of methacholine, a potent bronchoconstrictor, in a piglet model.
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and elimination of inhalational anesthetics.
 Data from the present porcine model of bronchoconstriction might be considered when admin-
istering inhalational anesthesia to asthmatic patients in clinical studies.1. Data
The data of an animal experiment on the effects of methacholine (MCh) infusion on desﬂurane
(DES) uptake and elimination are shared with this data article. It comprises baseline hemodynamics,
gas exchange and ventilation data in healthy piglets, and cardiopulmonary data during MCh infusion.
The mean values of hemodynamics, ventilation, and gas exchange prior to and during MCh infusion
are displayed in Tables 1 and 2, respectively.
The experimental protocol is presented in Fig. 1.
Multiple Inert Gas Elimination Technique (MIGET) was used to determine alveolar ventilation and
pulmonary perfusion distribution (V
.
A/Q
.
) before and during MCh infusion. The median values of
MIGET variables and IQR are given in Table 3. The fractional alveolar ventilation and pulmonary
perfusion in relation to the V
.
A/Q
.
compartments is displayed in Fig. 2.
Desﬂurane concentrations in arterial blood samples were analyzed by Micropore Membrane Inlet
Mass Spectrometry (MMIMS). Data on arterial blood desﬂurane during uptake and elimination are
displayed in Fig. 3. The infusion of MCh induced bronchoconstriction and impaired arterial oxyge-
nation did not affect desﬂurane pharmacokinetics.Table 1
Cardiopulmonary variables at baseline, prior to and after desﬂurane administration (n¼4). CO, MPAP, systemic and pulmonary
vascular resistance as well as arterial oxygenation remained constant as compared to baseline measurements in healthy piglets
during the ﬁrst experimental step: The wash-in of desﬂurane up to 1MAC did not affect general hemodynamics, respiratory
mechanics, ventilation or global gas exchange.
Parameter Baseline After DES wash-in After DES wash-out
MV (l/min) 5.3370.25 5.570.4 5.570.2
etCO2 (mmHg) 4371 4574 4574
VT (ml) 26078 277720 273711
PAWpeak (cmH2O) 18.970.1 18.370.2 18.770.1
PAWmean (cmH2O) 9.570.1 9.470.1 9.670.1
Rtot (cmH2O/l/s) 6.670.2 5.970.3 5.770.4
paO2 (mmHg) 172712 18976 19470
paCO2 (mmHg) 4374 4874 4871
SaO2 (%) 10070 9971 9971
pvO2 (mmHg) 4371 4171 4374
pvCO2 (mmHg) 5271 5475 5671
HR (1/s) 11377 11073 10071
MAP (mmHg) 8678 79712 6571
MPAP (mmHg) 2171 2172 2071
CVP (mmHg) 671 671 771
CO (l/min) 4.370.2 3.970.2 3.670.2
PVR (dyn*s/cm5) 284710 328755 313713
SVR (dyn*s/cm5) 1484761 14977308 1287730
MV minute ventilation, VT tidal volume; Paw airway pressure, Rtot total respiratory resistance, pa arterial partial pressure, SaO2
oxygen saturation in arterial blood, pv venous partial pressure, HR heart rate, MAP mean arterial pressure, MPAP mean pul-
monary arterial pressure, CVP central venous pressure, CO cardiac output, PVR pulmonary vascular resistance, and SVR sys-
temic vascular resistance.
Table 2
Cardiopulmonary variables prior to and after methacholine (MCh) administration by infusion (po0.05, in comparison with the
healthy state, n¼4). MCh given by infusion had signiﬁcant effects on respiratory mechanics and gas exchange as well. Cardiac
output was unaffected, and pvO2 did not change to any measurable degree. Peripheral vasodilation occurred as indicated by
lower MAP and decreased SVR. There was a threefold increase of total respiratory resistance (Rtot), and the airway pressure
(PAWpeak) were nearly doubled (po0.05). In addition, MCh infusion caused a fall in the paO2/FIO2 ratio (po0.05). The effects of
MCh were not affected by desﬂurane uptake up to 1MAC during the second wash-in/wash-out period (po0.05 in comparison
with healthy piglets at baseline).
Parameter During MCh
infusion
After Des washin
with MCh
After Des washout
with MCh
MV (l/min) 5.7670.4 6.1270.43 5.6370.22
etCO2 (mmHg) 4272 4174 4174
VT (ml) 26378 28379 25679
PAWpeak
(cmH2O)
3073.7 27.771.4 30.974.3
PAWmean
(cmH2O)
12.070.9 11.570.4 11.970.9
Rtot (cmH2O/l/s) 20.172.4 16.870.9 19.774.3
paO2 (mmHg) 103759 95739 87736
paCO2 (mmHg) 4872 5075 4974
SaO2 (%) 9871.5 9478 9177
pvO2 (mmHg) 3772 3573 3771
pvCO2 (mmHg) 6173 6176 6077
HR (1/s) 103717 105726 115718
MAP (mmHg) 6177 5775 6776
MPAP (mmHg) 2372 2472 2672
CVP (mmHg) 771 1072 1073
CO (l/min) 3.670.5 3.971.2 4.270.5
PVR (dyn*s/
cm5)
386726 312771 333789
SVR (dyn*s/cm5) 11977160 9877201 10907169
MV minute ventilation, VT tidal volume; Paw airway pressure, Rtot total respiratory resistance, pa arterial partial pressure, SaO2
oxygen saturation in arterial blood, pv venous partial pressure, HR heart rate, MAP mean arterial pressure, MPAP mean pul-
monary arterial pressure, CVP central venous pressure, CO cardiac output, PVR pulmonary vascular resistance, and SVR sys-
temic vascular resistance (Fig. 1).
Table 3
Median MIGET parameters and IQR prior to and after methacholine administration by infusion (*po0.05, in comparison with
the baseline healthy state). The quality of data was high as evidenced by low remaining sum of squares (RSS). MCh infusion and
DES inhalation up to 1 MAC increased dead space and shunt but reduced perfusion to normal V̇A/Q̇.
Variable Healthy lung MCh infusion MCh infusion þDES
Alveolar ventilation
%V in low V̇A/Q̇ 0 (0) 0 (0) 0 (0)
%V in normal V̇A/Q̇ 57.3(16.1) 54.5(3.5) 44.4(23)
%V in high V̇A/Q̇ 4.7 (7.2) 0 (0) 2.8 (8.4)
VD/VT (%) 38 (9) 45.4 (3.5) 52.9(14.7) *
mean of VA 1.5 (0.32) 1.03(0.02) 1.28(10.3)
Pulmonary perfusion
Shunt (%) 1.6 (0.7) 4.8 (3.2)* 8.3 (3.2) *
%Q in low V̇A/Q̇ 0 (0) 0 (0) 2.9 (8.8) *
%Q in normal V̇A/Q̇ 97.7 (0.8) 95.3 (3.2) 84 (19.4) *
%Q in high V̇A/Q̇ 0.2 (0.6) 0 (0) 3.8 (11.5) *
mean of Q 1.02(0.36) 0.79(0.05) 1.2 (0.74)
Global parameters
log SDQ 0.5 (0.1) 0.5 (0.1) 0.9 (1.2)
log SDV 1 (0.5) 0.5 (0.1) 0.6 (0.3)
Accuracy
RSS 2.7 (1) 1.3 (1) 3.3 (2.6)
A alveolar, V ventilation, Q perfusion, VD/VT dead space, and RSS remaining sum of squares.
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Fig. 1. Experimental timeline. ARM Alveolar Recruitment Maneuver, MMIMS Micropore Membrane Inlet Mass Spectrometry,
MIGET Multiple Inert Gas Elimination Technique.
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Fig. 2. MIGET fractional ventilation (V) and pulmonary perfusion (Q) by different V̇/Q̇ ratios at baseline (A) and during MCh
infusion (B). The data represents the averaged moments of ventilation and perfusion distribution of all piglets. Note that there
is no difference induced by infusion of MCh in comparison to healthy animals. MCh Methacholine, MIGET Multiple Inert Gas
Elimination Technique, Q Pulmonary Perfusion, V Alveolar Ventilation, VD Dead Space.
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2.1. General
The present experimental design, materials and methods are in accordance with the corre-
sponding experiment on the effects of MCh inhalation on desﬂurane pharmacokinetics [1]. It was
Desflurane uptake into arterial blood (n=4)
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time (min)
0 10 20 30
re
la
tiv
e 
M
M
IM
S
 s
ig
na
l
0,0
0,2
0,4
0,6
0,8
1,0
desflurane signal, healthy piglets
desflurane signal during MCh infusion
ah 0.71 a M 0.78
bh 2.16 b M 2,24
ch 0.30 c M 0.22
dh 0.48 d M 0.27
Desflurane elimination from arterial blood (n=4)
scaled to plateau arterial MMIMS signal 
time (min)
0 10 20 30
re
la
tiv
e 
M
M
IM
S
 s
ig
na
l
0,0
0,2
0,4
0,6
0,8
1,0
desflurane signal, healthy piglets
desflurane signal during MCh infusion
ah 0.76 a M 0.73
bh 2.63 b M 2.39
ch 0.24 c M 0.26
dh 0.08 d M 0.07
Fig. 3. Time course of desﬂurane uptake (A) into and elimination (B) from arterial blood in healthy (h) and MCh injured piglets
(M). Data were calculated as means (SD) after scaling the MMIMS signals in the individual piglet to the arterial plateau after
30 min. The infusion of MCh induced bronchoconstriction and impaired arterial oxygenation but did not affect desﬂurane
pharmacokinetics. Enclosed are the mean coefﬁcients (a, b, c, d) of the exponential regression functions yu¼ f(x)¼a(1e-bx)þc
(1edx) and ye¼ f(x)¼a(ebx)þc(edx), displayed for uptake (u) and elimination (e) of desﬂurane. MMIMS Micropore
Membrane Inlet Mass Spectrometry, MCh Methacholine, h healthy, M MCh injured.
A. Kozian et al. / Data in Brief 5 (2015) 939–947944scheduled as a prospective, controlled, animal trial in a single cohort of juvenile piglets. The Animal
Ethics Committee of Uppsala University (Sweden) approved the experimental protocol. The care and
handling of animals were in accordance with National Institutes of Health guidelines for ethical
animal treatment [2].2.2. Animals
Healthy, 2.5-month-old piglets (26.770.5 kg) of mixed Yorkshire/Norwegian country breeds
obtained from a local breeder were included (n¼4). The animals fasted overnight with free access to
water. All animals underwent the same routine instrumentation and monitoring algorithm including
induction and maintenance of intravenous anesthesia.
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The animals were anesthetized by an i.m. injection of xylazine (2.2 mg kg1, Rompuns; Bayer,
Leverkusen, Germany), and tiletamine/zolazepam (6 mg kg1, Zoletils; Virbac, Carros, France). The
animals were placed in supine position and general anesthesia was continued by infusions of fentanyl
(Leptanals; Janssen-Cilag AB, Sweden; 0.04 mg kg1 h1), midazolam (0.12 mg kg1 h1, Midazolam
Actavis, Actavis Group, Hafnersfjordur, Iceland), and propofol (Diprivans; Astra, Södertälje, Sweden;
6 mg kg1 h1) via 18G catheters (Becton Dickinson, Heidelberg, Germany), placed in ear veins. The
absence of consciousness was veriﬁed by testing the corneal reﬂex and the hind limb reﬂex response,
and muscle relaxation was induced with a bolus of rocuronium bromide (2 mg kg1, Esmerons, N.V.
Organon, Oss, Netherlands) followed by a continuous infusion of the same drug at 2.5 mg kg1 h1.
The trachea was intubated with an ID 7.0 mm cuffed endotracheal tube (Mallinckrodt, Athlone, Ire-
land). The animals were mechanically ventilated with intermittent positive pressure ventilation
(IPPV) with an inspiration/expiration ratio of 1:2, inspired oxygen fraction (FIO2) of 0.4 and PEEP of
5cmH2O provided by a KIONs anesthesia ventilator (Maquet Critical Care, Solna, Sweden). The tidal
volume (VT) was set to 10 ml kg1, and respiratory frequency was adjusted to achieve a normal
arterial pCO2 of 40 mmHg. Exhaled end-tidal CO2 (etCO2), gas ﬂow and airway pressures were
measured at the proximal end of the tracheal tube with a NICO capnograph (Respironics, Wallingford,
CT). A FIO2 of 0.4 was maintained throughout the experiment.
A 14G catheter was placed in one of the front limbs for MIGET infusion and a ﬂow-directed pul-
monary artery catheter (PAC, 7.0 French, Swan-Ganz thermodilution catheter, Baxter, Irvine, CA, USA)
and a single lumen central venous catheter (4.0 French, Becton-Dickinson Critical Care Systems,
Singapore) were inserted via the right internal jugular vein. The PAC was used for cardiac output
measurements and mixed venous blood sampling. Temperature was also measured by PAC and
maintained at 37.570.5 °C by use of heating mats. The PAC was repositioned frequently to ensure
that the tip was always located in regions with high pulmonary blood ﬂow. Hemodynamic para-
meters (cardiac output (CO), heart rate (HR), mean arterial pressure (MAP), mean pulmonary arterial
pressure (MPAP), central venous pressure (CVP) and peripheral capillary oxygen saturation (SpO2)
were monitored continuously with a SC 9000 XL Monitor (Siemens, Erlangen, Germany) and recorded
at each experimental setting.
An arterial catheter was inserted into the right carotid artery for continuous arterial pressure
measurements and a hind limb arterial catheter for blood sampling (20G; Becton-Dickinson Critical
Care Systems).
Blood gas analysis was performed immediately after bubble free blood sampling with standard
blood gas electrodes (ABL 500; Radiometer, Copenhagen, Denmark). The blood gas analyzer was
calibrated (one-point every hour and two-points every four hours) by internal routines, and always
before the day's measurements. Finally, a suprapubic urinary catheter (Sympakath; Ruesch AG, St
Gallen, Switzerland) was placed for monitoring of urine output. After completion of general pre-
paration, an alveolar recruitment maneuver (inspiratory hold, 40cmH2O, for 10 s) was performed, and
the piglets were allowed 30 min for stabilization.
The animals received 1072 ml kg1 h1 of saline (Fresenius Kabi AB; Halden, Norway). At the end
of the experiment, the animals were euthanized with an i.v. injection of potassium chloride (150 meq)
while under general anesthesia.
2.4. Multiple inert gas elimination technique (MIGET)
For MIGET, six inert gases were dissolved in saline and infused into a peripheral vein at a constant
rate. Samples of mixed venous blood (input of gases to the lung), systemic arterial blood (gases
retained in the lung in blood phase) and mixed expired gas (gases excreted from the lung in gas
phase) were analyzed for their inert gas partial pressures. The differences in the way the lung retains
or excretes gases of different solubility were analyzed to determine a compatible distribution of the
ventilation/perfusion ratios (V
.
A/Q
.
) [3].
The inert gas infusion was saline with added sulfurhexaﬂuoride (SF6), ethane and cyclopropane
(by bubbling) and enﬂurane, diethyl ether and acetone (by liquid injection). This mixture was infused
A. Kozian et al. / Data in Brief 5 (2015) 939–947946into a peripheral vein at a rate of 3 ml/min. Determination of V
.
A/Q
.
was carried out four times: before
desﬂurane application and at the plateau state after wash-in in both healthy piglets and during
methacholine administration (i.e. during bronchoconstriction). Blood samples for MIGET were col-
lected simultaneously from the pulmonary artery and systemic artery catheters in 10 ml gas-tight,
ungreased, matched barrel glass syringes (Popper & Sons, now Cadence Science, Staunton, VA, USA)
preﬁlled with heparin. Mixed expired gas samples were collected in dry 20 ml, matched barrel glass
syringes from a heated (440 °C) mixing chamber (volume 2.5 l) connected to the ventilator outlet.
Analysis of the gas samples by gas chromatography (GC, Model 5890, Series II; Hewlett-Packard,
Waltham, MA) and calculations were carried out as previously reported [4,5].
2.5. Anesthesia gas measurement by mass spectrometry
Arterial blood samples were collected in glass syringes coated with EDTA (FORTUNAs OPTIMAs,
5 ml, Luer-lock, Poulten&Graf GmbH, Wertheim, Germany) for analysis by Micropore Membrane Inlet
Mass Spectrometry (MIGET by MMIMS System, Oscillogys, Folsom, PA, USA).
For analysis, the blood samples ﬂowed over the MMIMS probes and the volatile gas partial
pressures were analyzed directly. The user entered essential physiologic data (cardiac output, minute
ventilation, core body temperature) into the machine, and the system adjusted the probe and sample
temperatures to match core temperature. Systemic artery blood samples and mixed expired gas
samples were injected into the machine. The system ﬂows each sample over a microporous mem-
brane inlet probe, measures the current signal from the mass spectrometer at m/e¼101 for des-
ﬂurane, identiﬁes the plateau signal and averages that signal [6–9].
2.6. Experimental protocol(1) Baseline: Following a lung recruitment maneuver (inspiratory hold function of the respirator,
40cmH2O, for 10 s) and stabilization period, baseline hemodynamic, ventilation, and gas
exchange data were obtained.
(1) Healthy state: Desﬂurane (Supranes, Baxter) was administered via the KION ventilator with the
vaporizer set at 1 MAC (E6 vol%) in an open system with fresh gas ﬂow set to exceed double
minute ventilation. End-tidal gas samples as well as arterial blood were obtained simultaneously
at 0, 1, 2, 5, 10, 20 and 30 min (volatile uptake, wash-in). In a second step, administration of
desﬂurane was stopped and the sampling was repeated (volatile elimination, wash-out).
(1) Induction of bronchoconstriction: This was induced by infusion of methacholine (MCh) (Acetyl-ß-
methacholine chloride, Sigma-Aldrich Inc. St. Louis, Mo, USA). Infusion was performed con-
tinuously with 100 mg/ml MCh in normal saline at 50–100 ml/h and adjusted to maintain
doubling of peak airway pressure in each pig throughout the second part of the experiment.
Thereafter, desﬂurane uptake and elimination measurements were repeated during MCh
infusion, using the same timing schedule.
The workﬂow of the experimental protocol is presented in Fig. 1.
2.7. Data analysis
Data analysis was performed with the Statistical Package for the Social Sciences (SPSS, v. 22, IBM
Corporation, Armonk, New York, USA) and SigmaPlots v. 11 (Systat Software Inc., San Jose, CA, USA).
The estimation of sample size was based on previous experimental studies, which used an analogous
experimental setup [1,10–12]. Power calculation using a two-sided design at a signiﬁcance level of 5%
(α¼0.05) and a power of 80% (β¼0.20) revealed that at least 4 animals per group were needed to
detect a difference of more than 20% in the time to P90 arterial desﬂurane concentrations during MCh
inhalation [1]. This time point was deﬁned as the primary variable.
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means and standard deviations in the case of normal distribution (cardiopulmonary and ventilation
variables). Nonlinear regression analysis of MMIMS data was performed with Sigmaplots. The curves
are displayed as mean of data points with standard deviations.
The analysis of normally distributed data was performed by a repeated measures one-way analysis
of variance (ANOVA) with post-hoc Bonferroni correction. The V
.
A/Q
.
distributions were compared
after calculations of moments of the distributions (mean V
.
A/Q
.
, Vmean, Qmean, logSDV, logSDQ and
skewness) by nonparametric Friedman's test and Wilcoxon's matched pairs test [13].
No data were lost during the experiment or were missed in the statistical analysis. The differences
were considered to be statistically signiﬁcant for all procedures if po0.05.Acknowledgments
The authors wish to express their special gratitude to Agneta Ronéus, Chief Technician, and to
Karin Fagerbrink, Annelie Ryden, and Maria Svaelas, Laboratory Technicians, Hedenstierna Laboratory,
Uppsala University, Uppsala, Sweden, for their help and support during the experiment. Their work
and their assistance in instrumentation and monitoring of the animals as well as blood sampling and
data recording are greatly appreciated. The authors especially acknowledge the work of Eva-Maria
Hedin, who performed the MIGET measurements.Appendix A. Supplementary material
Supplementary data associated with this article can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2015.11.002.References
[1] M. Kretzschmar, et al., Bronchoconstriction induced by inhaled methacholine delays desﬂurane uptake and elimination in a
piglet model, Respir. Physiol. Neurobiol. 9 (220) (2015) 88–94. http://dx.doi.org/10.1016/j.resp.2015.09.014 [Epub ahead of
print].
[2] National Research Council (US) Committee on Regulatory Issues in Animal Care and Use, Deﬁnition of pain and distress and
reporting requirements for laboratory animals, in: Proceedings of the Workshop Held June 22, National Academies Press,
US, Washington, DC, 2000.
[3] J.W. Evans, P.D. Wagner, Limits on VA/Q distributions from analysis of experimental inert gas elimination, J. Appl. Physiol.
Respir. Environ. Exerc. Physiol. 42 (1977) 889–898.
[4] T. Hachenberg, et al., Ventilation–perfusion inequality in patients undergoing cardiac surgery, Anesthesiology 80 (1994)
509–519.
[5] H.U. Rothen, et al., Inﬂuence of gas composition on recurrence of atelectasis after a reexpansion maneuver during general
anesthesia, Anesthesiology 82 (1995) 832–842.
[6] J.E. Baumgardner, Q.J., G.R. Neufeld, Micropore membrane inlet mass spectrometer probes suitable for measurement of
tissue surface gas tensions, J. Mass Spectrom. 30 (1995) 563–571.
[7] J.E. Baumgardner, et al., Sequential V(A)/Q distributions in the normal rabbit by micropore membrane inlet mass spec-
trometry, J. Appl. Physiol. 89 (2000) 1699–1708.
[8] B. Duenges, et al., A comparison of micropore membrane inlet mass spectrometry-derived pulmonary shunt measurement
with Riley shunt in a porcine model, Anesth. Analg. 109 (2009) 1831–1835.
[9] M. Kretzschmar, et al., Multiple inert gas elimination technique by micropore membrane inlet mass spectrometry—a
comparison with reference gas chromatography, J. Appl. Physiol. 115 (2013) 1107–1118.
[10] A. Kozian, et al., One-lung ventilation induces hyperperfusion and alveolar damage in the ventilated lung: an experimental
study, Br. J. Anaesth. 100 (2008) 549–559.
[11] A. Kozian, et al., Increased alveolar damage after mechanical ventilation in a porcine model of thoracic surgery, J. Car-
diothorac. Vasc. Anesth. 24 (2010) 617–623.
[12] A. Kozian, et al., Ventilatory protective strategies during thoracic surgery: effects of alveolar recruitment maneuver and
low-tidal volume ventilation on lung density distribution, Anesthesiology 114 (2011) 1025–1035.
[13] W. Conover, Practical Nonparametric Statistics, John Wiley and Sons, New York, 1999.
